AI assistant
HAEMONETICS CORP — Director's Dealing 2010
Oct 29, 2010
31565_dirs_2010-10-29_351dfaec-2c1d-4466-af5e-187dfb8cfc9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-10-27
Reporting Person: Brancazio Phillip John (VP, Global Manufacturing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-10-27 | Common Stock | A | 1363.0000 | $0.0100 | Acquired | 2911.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-10-27 | Non-Qualified Stock Option (right to buy) | $54.9900 | A | 11837.0000 | Acquired | 2017-10-27 | Common Stock (11837) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $52.9400 | 2016-10-27 | Common Stock (12242) | 12242.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $58.6400 | 2016-07-29 | Common Stock (11441) | 11441.0000 | Direct |
Footnotes
F1: Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.